Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azithromycin addition to cefazolin for elective cesarean section
NCT03502356Phase 2Unknown
- Sponsor
- Ain Shams University
- Start
- Apr 2018
- Primary completion
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of azithromycin in endometritis and post-operative infection (2 arms), sponsored by Ain Shams University. Primary endpoint: Endometritis at 6 weeks. Status: unknown.
02
Drugs
azithromycin
03
Conditions
endometritispost-operative infection
Beyond the preview
Go deeper on NCT03502356.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03502356.